Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-21 · accession 0001870913-24-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-24 | 2024-06-21 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $58.90 | -20.0K | 682.6K | -3% | -$1.18M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | S | D | 20,000 | $58.90 | 682,620 | I Held by Esjay LLC | — | — | (F2) The shares were sold in multiple trades at prices ranging from $58.43 to $59.48. The price reported above reflects the weighted average sales price. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |